IN8bio Inc (NASDAQ:INAB) price on Wednesday, May 21, fall -3.08% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.13.
A look at the stock’s price movement, the close in the last trading session was $0.13, moving within a range at $0.124 and $0.1319. The beta value (5-Year monthly) was 0.225. Turning to its 52-week performance, $1.74 and $0.11 were the 52-week high and 52-week low respectively. Overall, INAB moved -27.79% over the past month.
IN8bio Inc’s market cap currently stands at around $11.44 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-06.
Turning to the stock’s technical picture we see that short term indicators suggest on average that INAB is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend INAB as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
INAB’s current price about -20.38% and -28.54% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 28.53, while 7-day volatility ratio is 11.75% and 8.21% in the 30-day chart. Further, IN8bio Inc (INAB) has a beta value of 0.12, and an average true range (ATR) of 0.01.
If we refocus on IN8bio Inc (NASDAQ:INAB), historical trading data shows that trading volumes averaged 3.05 over the past 10 days and 1.36 million over the past 3 months. The company’s latest data on shares outstanding shows there are 81.26 million shares.
The 21.49% of IN8bio Inc’s shares are in the hands of company insiders while institutional holders own 17.96% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.43 million on 2025-04-30, giving us a short ratio of 0.59. The data shows that as of 2025-04-30 short interest in IN8bio Inc (INAB) stood at 63.0 of shares outstanding, with shares short falling to 1.01 million registered in 2025-03-31. Current price change has pushed the stock -51.01% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the INAB stock continues to rise going into the next quarter.
